Clinical Trial Update: Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effects of probenecid, rifampin, and verapamil on bexagliflozin in healthy subjects completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Bexagliflozin (null)
• Probenecid (probenecid)
• RIFAMPIN (RIFAMPIN)
• Verapamil (verapamil)

Snippet

Sponsor: Theracos | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2021-04-27